KIMBERLY WINGARD: Open Payments
NPI 1659856532 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,632 in 54 payments from 12 companies in 2025. Trend: 2023 $514 · 2024 $611 · 2025 $1,632
Food & beverage: $1,632
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $570 |
| Axsome Therapeutics, Inc. | 14 | $484 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $100 |
| Luye Pharma (USA) Ltd. | 1 | $90 |
| Janssen Pharmaceuticals, Inc | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Tempus AI, Inc | 2 | $58 |
| Lundbeck LLC | 2 | $50 |
| Indivior Inc. | 2 | $49 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
Products named: CAPLYTA, Auvelity, REXULTI, TRINTELLIX, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA, TEMPUS PIXEL, SUBLOCADE.
Industry payments across TX — which companies pay providers there.
